#TITLE_ALTERNATIVE#
Diabetic nephropathy is a microvascular complication of diabetes melitus characterized by chronic <br /> <br /> kidney disease (CKD). The main component in the diabetic nephropathy therapy is the use of <br /> <br /> antidiabetic and antihypertension in controlling blood gluc...
Saved in:
Main Author: | |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/28854 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
id |
id-itb.:28854 |
---|---|
spelling |
id-itb.:288542018-09-28T13:17:39Z#TITLE_ALTERNATIVE# NUR ASTIANI NIM : 11614014, MELI Indonesia Final Project INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/28854 Diabetic nephropathy is a microvascular complication of diabetes melitus characterized by chronic <br /> <br /> kidney disease (CKD). The main component in the diabetic nephropathy therapy is the use of <br /> <br /> antidiabetic and antihypertension in controlling blood glucose levels and blood pressure to slow <br /> <br /> the rate of kidney damage. The purpose of this study was to determine the pattern of treatment <br /> <br /> and drugs usage, as well as evaluate the accuracy of the usage of antidiabetic and antihypertension <br /> <br /> to patients with diabetic nephropathy in one of Bandung Private Hospitals based on based on <br /> <br /> aspects of right indication, right drug, and right dose. This study is a analytic obeservational <br /> <br /> retrospectively study by reviewing data from medical records in the period of January 2016 - <br /> <br /> December 2017. The results showed that the antidiabetic treatment pattern in diabetic <br /> <br /> nephropathy patients was monotherapy glimepirid. The evaluation results for the accuracy of <br /> <br /> antidiabetic usage showed 100% exact indication, 93.93% right medication, and 100% right dose. <br /> <br /> Treatment results during hospitalization showed 66.67% had blood glucose levels when under <br /> <br /> control and 33.33% had blood glucose levels when uncontrolled. While the antihypertension <br /> <br /> treatment pattern in diabetic nephropathy patients was the use of a combination of angiotensin <br /> <br /> receptor blocker (ARB) and calcium channel blocker (CCB), the most widely used antihypertension <br /> <br /> is the CCB group, namely amlodipine. The evaluation results for the accuracy of antihypertension <br /> <br /> usage showed 100% exact indications, 88.89% right medication, and 91.67% right dose. Treatment <br /> <br /> results during hospitalization showed 63.89% had controlled blood pressure and 36.11% had <br /> <br /> uncontrolled blood pressure. <br /> text |
institution |
Institut Teknologi Bandung |
building |
Institut Teknologi Bandung Library |
continent |
Asia |
country |
Indonesia Indonesia |
content_provider |
Institut Teknologi Bandung |
collection |
Digital ITB |
language |
Indonesia |
description |
Diabetic nephropathy is a microvascular complication of diabetes melitus characterized by chronic <br />
<br />
kidney disease (CKD). The main component in the diabetic nephropathy therapy is the use of <br />
<br />
antidiabetic and antihypertension in controlling blood glucose levels and blood pressure to slow <br />
<br />
the rate of kidney damage. The purpose of this study was to determine the pattern of treatment <br />
<br />
and drugs usage, as well as evaluate the accuracy of the usage of antidiabetic and antihypertension <br />
<br />
to patients with diabetic nephropathy in one of Bandung Private Hospitals based on based on <br />
<br />
aspects of right indication, right drug, and right dose. This study is a analytic obeservational <br />
<br />
retrospectively study by reviewing data from medical records in the period of January 2016 - <br />
<br />
December 2017. The results showed that the antidiabetic treatment pattern in diabetic <br />
<br />
nephropathy patients was monotherapy glimepirid. The evaluation results for the accuracy of <br />
<br />
antidiabetic usage showed 100% exact indication, 93.93% right medication, and 100% right dose. <br />
<br />
Treatment results during hospitalization showed 66.67% had blood glucose levels when under <br />
<br />
control and 33.33% had blood glucose levels when uncontrolled. While the antihypertension <br />
<br />
treatment pattern in diabetic nephropathy patients was the use of a combination of angiotensin <br />
<br />
receptor blocker (ARB) and calcium channel blocker (CCB), the most widely used antihypertension <br />
<br />
is the CCB group, namely amlodipine. The evaluation results for the accuracy of antihypertension <br />
<br />
usage showed 100% exact indications, 88.89% right medication, and 91.67% right dose. Treatment <br />
<br />
results during hospitalization showed 63.89% had controlled blood pressure and 36.11% had <br />
<br />
uncontrolled blood pressure. <br />
|
format |
Final Project |
author |
NUR ASTIANI NIM : 11614014, MELI |
spellingShingle |
NUR ASTIANI NIM : 11614014, MELI #TITLE_ALTERNATIVE# |
author_facet |
NUR ASTIANI NIM : 11614014, MELI |
author_sort |
NUR ASTIANI NIM : 11614014, MELI |
title |
#TITLE_ALTERNATIVE# |
title_short |
#TITLE_ALTERNATIVE# |
title_full |
#TITLE_ALTERNATIVE# |
title_fullStr |
#TITLE_ALTERNATIVE# |
title_full_unstemmed |
#TITLE_ALTERNATIVE# |
title_sort |
#title_alternative# |
url |
https://digilib.itb.ac.id/gdl/view/28854 |
_version_ |
1822021851895824384 |